These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33583280)

  • 1. Enhanced detection of ATTR amyloid using a nanofibril-based assay.
    Rahman MM; Schmuck B; Hansson H; Härd T; Westermark GT; Sandgren M
    Amyloid; 2021 Sep; 28(3):158-167. PubMed ID: 33583280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The revolution of ATTR amyloidosis in cardiology: certainties, gray zones and perspectives.
    Rapezzi C; Vergaro G; Emdin M; Fabbri G; Cantone A; Sanguettoli F; Aimo A
    Minerva Cardiol Angiol; 2022 Apr; 70(2):248-257. PubMed ID: 35412035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transthyretin: Its function and amyloid formation.
    Ueda M
    Neurochem Int; 2022 May; 155():105313. PubMed ID: 35218869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic testing improves identification of transthyretin amyloid (ATTR) subtype in cardiac amyloidosis.
    Brown EE; Lee YZJ; Halushka MK; Steenbergen C; Johnson NM; Almansa J; Tedford RJ; Cingolani O; Russell SD; Sharma K; Judge DP
    Amyloid; 2017 Jun; 24(2):92-95. PubMed ID: 28494620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytodiagnosis and protein typing of amyloid from a vitreous washing: initial diagnostic workup of hereditary amyloidosis.
    Coppock JD; Dusenbery AC; Elghawy O; Fellenstein LA; Frierson HF; Shildkrot Y
    J Am Soc Cytopathol; 2020; 9(3):173-176. PubMed ID: 32113804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CNS involvement in V30M transthyretin amyloidosis: clinical, neuropathological and biochemical findings.
    Maia LF; Magalhães R; Freitas J; Taipa R; Pires MM; Osório H; Dias D; Pessegueiro H; Correia M; Coelho T
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):159-67. PubMed ID: 25091367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinctive Patterns of Transthyretin Amyloid in Salivary Tissue: A Clinicopathologic Study of 92 Patients With Amyloid-containing Minor Salivary Gland Biopsies.
    Jamet MP; Gnemmi V; Hachulla É; Dhaenens CM; Bouchindhomme B; Delattre C; Glowacki F; Hatron PY; Lacour A; Lamblin N; Launay D; Leleu X; Guiochon-Mantel A; Valleix S; Maurage CA; Copin MC; Buob D
    Am J Surg Pathol; 2015 Aug; 39(8):1035-44. PubMed ID: 25828388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical diversity, diagnosis and treatment of hereditary amyloid neuropathy].
    Sekijima Y
    Rinsho Shinkeigaku; 2014; 54(12):953-6. PubMed ID: 25672679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid.
    Eriksson M; Büttner J; Todorov T; Yumlu S; Schönland S; Hegenbart U; Kristen AV; Dengler T; Lohse P; Helmke B; Schmidt H; Röcken C
    Am J Surg Pathol; 2009 Jan; 33(1):58-65. PubMed ID: 18830126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. One mutation, two distinct disease variants: unravelling the impact of transthyretin amyloid fibril composition.
    Suhr OB; Lundgren E; Westermark P
    J Intern Med; 2017 Apr; 281(4):337-347. PubMed ID: 28093848
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy.
    Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G
    J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH.
    Ueda M; Okada M; Mizuguchi M; Kluve-Beckerman B; Kanenawa K; Isoguchi A; Misumi Y; Tasaki M; Ueda A; Kanai A; Sasaki R; Masuda T; Inoue Y; Nomura T; Shinriki S; Shuto T; Kai H; Yamashita T; Matsui H; Benson MD; Ando Y
    J Biol Chem; 2019 Jul; 294(29):11259-11275. PubMed ID: 31167790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between spinal stenosis and wild-type ATTR amyloidosis.
    Godara A; Riesenburger RI; Zhang DX; Varga C; Fogaren T; Siddiqui NS; Yu A; Wang A; Mastroianni M; Dowd R; Nail TJ; McPhail ED; Kurtin PJ; Theis JD; Toskic D; Arkun K; Pilichowska M; Kryzanski J; Patel AR; Comenzo R
    Amyloid; 2021 Dec; 28(4):226-233. PubMed ID: 34263670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy.
    Adams D; Ando Y; Beirão JM; Coelho T; Gertz MA; Gillmore JD; Hawkins PN; Lousada I; Suhr OB; Merlini G
    J Neurol; 2021 Jun; 268(6):2109-2122. PubMed ID: 31907599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Late onset cardiomyopathy as presenting sign of ATTR A45G amyloidosis caused by a novel TTR mutation (p.A65G).
    Klaassen SHC; Lemmink HH; Bijzet J; Glaudemans AWJM; Bos R; Plattel W; van den Berg MP; Slart RHJA; Nienhuis HLA; van Veldhuisen DJ; Hazenberg BPC
    Cardiovasc Pathol; 2017; 29():19-22. PubMed ID: 28460244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of albumin on transthyretin and amyloidogenic transthyretin Val30Met disposition and tissue deposition in familial amyloidotic polyneuropathy.
    Taguchi K; Jono H; Kugimiya-Taguchi T; Nagao S; Su Y; Yamasaki K; Mizuguchi M; Maruyama T; Ando Y; Otagiri M
    Life Sci; 2013 Dec; 93(25-26):1017-22. PubMed ID: 24211615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathological, biochemical, and biophysical characteristics of the transthyretin variant Y114H (p.Y134H) explain its very mild clinical phenotype.
    Sekijima Y; Campos RI; Hammarström P; Nilsson KP; Yoshinaga T; Nagamatsu K; Yazaki M; Kametani F; Ikeda S
    J Peripher Nerv Syst; 2015 Dec; 20(4):372-9. PubMed ID: 26306725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRANSTHYRETIN AMYLOIDOSIS THERAPIES: GUIDING THE FUTURE.
    González-Duarte A
    Rev Invest Clin; 2021; 73(5):310-315. PubMed ID: 34609369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.